Biohaven Ltd [BHVN] stock is trading at $40.18, up 3.56%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BHVN shares have gain 3.77% over the last week, with a monthly amount drifted -20.89%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Biohaven Ltd [NYSE: BHVN] stock has seen the most recent analyst activity on February 16, 2024, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $62. Previously, UBS started tracking the stock with Buy rating on February 06, 2024, and set its price target to $59. On December 22, 2023, H.C. Wainwright initiated with a Buy rating and assigned a price target of $50 on the stock. Robert W. Baird started tracking the stock assigning a Outperform rating and suggested a price target of $58 on December 08, 2023. SVB Securities initiated its recommendation with a Outperform and recommended $24 as its price target on January 24, 2023. JP Morgan started tracking with a Overweight rating for this stock on January 04, 2023, and assigned it a price target of $23. In a note dated December 02, 2022, BTIG Research initiated an Buy rating and provided a target price of $24 on this stock.
Biohaven Ltd [BHVN] stock has fluctuated between $12.96 and $62.21 over the past year. Currently, Wall Street analysts expect the stock to reach $23.5 within the next 12 months. Biohaven Ltd [NYSE: BHVN] shares were valued at $40.18 at the most recent close of the market. An investor can expect a potential drop of -41.51% based on the average BHVN price forecast.
Analyzing the BHVN fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.8, Equity is -1.03 and Total Capital is -0.95. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 38.53 points at the first support level, and at 36.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.74, and for the 2nd resistance point, it is at 43.29.
Biohaven Ltd [BHVN] reported earnings per share of -$1.81 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1.41/share, meaning a difference of -$0.4 and a surprise factor of -28.40%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$1.5 per share as compared to estimates of -$1.34 per share, a difference of -$0.16 representing a surprise of -11.90%.
Ratios To Look Out For
For context, Biohaven Ltd’s Current Ratio is 7.98. As well, the Quick Ratio is 7.98, while the Cash Ratio is 4.51.
Transactions by insiders
Recent insider trading involved Bailey Gregory, Director, that happened on Apr 24 ’24 when 25503.0 shares were purchased. Director, CHILDS JOHN W completed a deal on Apr 22 ’24 to buy 0.2 million shares. Meanwhile, Chief Executive Officer Coric Vlad bought 0.12 million shares on Apr 22 ’24.
